SCHEMBL10057682

SCHEMBL10057682

CC(C)N1CCC(O)(c2ccc(F)c(C(F)(F)F)c2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 17/20 0.48
OPRD1 P41143 13/20 0.48
OPRL1 P41146 12/20 0.48
OPRK1 P41145 12/20 0.43
HTR1A P08908 6/20 0.43
DRD2 P14416 6/20 0.43
DRD4 P21917 6/20 0.43
HTR1D P28221 6/20 0.43
HTR2A P28223 6/20 0.43
HTR2C P28335 6/20 0.43
HTR7 P34969 6/20 0.43
HRH2 P25021 5/20 0.43
DRD1 P21728 5/20 0.43
DRD5 P21918 5/20 0.43
SLC6A2 P23975 5/20 0.43
SLC6A4 P31645 5/20 0.43
DRD3 P35462 5/20 0.43
HTR2B P41595 5/20 0.43
HTR6 P50406 5/20 0.43
SLC6A3 Q01959 5/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10078310 0.85 OPRL1 (0.49) OPRM1OPRD1OPRL1OPRK1HTR1A
SCHEMBL3857799 0.81 OPRL1 (0.55) OPRM1OPRD1OPRL1OPRK1HTR1A
SCHEMBL10057684 0.81 CYP2D6 (0.48) OPRM1OPRD1OPRL1OPRK1SLC6A2
SCHEMBL2929705 0.79 OPRL1 (0.53) OPRM1OPRD1OPRL1OPRK1HTR1A
SCHEMBL10057649 0.79 OPRL1 (0.60) OPRM1OPRD1OPRL1OPRK1DRD2
SCHEMBL3860368 0.78 OPRL1 (0.46) OPRM1OPRD1OPRL1OPRK1HTR1A
SCHEMBL10057650 0.77 OPRL1 (0.63) OPRM1OPRD1OPRL1OPRK1DRD2
SCHEMBL10057646 0.76 OPRM1 (0.63) OPRM1OPRD1OPRL1OPRK1
SCHEMBL3115638 0.76 RORC (0.41) OPRM1OPRD1OPRL1OPRK1SLC6A2
SCHEMBL2268801 0.76 DRD2 (0.51) OPRM1OPRD1OPRL1OPRK1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148404-B2 Modulators of CB1 receptors 7TM PHARMA A/S (DK) 2012-04-03 US disclosed
US-20100144701-A1 Modulators of CB1 Receptors 7TM PHARMA A/S (DK) 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144701-A1 Modulators of CB1 Receptors CNR1, CNR2, GPR6 OPRM1 81/4885OPRD1 78/4885OPRL1 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.